[370 Pages Report] The global diagnostic x-ray system market is expected to enjoy a valuation of US$ 11.30 Billion by the end of the year 2022, and further expand at a CAGR rate of 6.1% to reach a valuation of ~US$ 20.46 Billion by the year 2032. According to a recent study by Future Market Insights, Medical X-ray Devices are leading the market with a share of over 65% in the year 2021, within the global market.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | US$ 11.30 Billion |
Market Value 2032 | US$ 20.46 Billion |
CAGR 2022 to 2032 | 6.1% |
Market Share of Top 5 Countries | 54.8% |
Key Market Players | Shimadzu Corporation, Medlink Imaging, LLC, Konica Minolta Healthcare Americas, Inc., Leidos, ODSecurity, Rigaku Corporation, Anton Paar GmbH, Braun & Co. Limited, Xenoc, Proto Manufacturing, OSI Systems, Siemens Healthineers, General Electric Company, FUJIFILM Holdings Corp, Koninklijke Philips N.V., Carestream Health, Canon Medical Systems Corporation, Smiths Detection Group Ltd., Thermo Fisher Scientific Inc., Astrophysics Inc., Malvern Panalytical Ltd, NUCTECH COMPANY LTD, Bruker. |
X-Ray technology has been used for a long time in the form of medical diagnostics equipment in order to produce images of the internal structure of an individual. The ionizing radiation of X-Rays passes through the body as X-Ray beams, which are then absorbed in varying amounts as per the bone material density. Mammography, digital radiography (DR), and interventional radiology are some of the types of X-Ray devices. One such method is X-ray diffraction or XRD which is used to examine the molecular structure of materials using X-Rays.
Nowadays, X-ray security screening systems are also highly preferred for security purposes in various public places, such as airports, railways station, and others. Scanning of an individual or their baggage across venues including government offices, airports, and even border terminal points is done to avoid letting hazardous objects within the secured premises.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for the diagnostic x-ray system market was approximately 24% of the overall ~US$ 45.0 Billion of the global medical imaging equipment market in 2021.
The sale of the diagnostic x-ray system market expanded at a CAGR of 3.5% from 2012 to 2021, owing to the rising number of imaging procedures globally.
The market for X-Ray systems is expected to show attractive growth in the future. There are consistently growing advancements and precision in the imaging market. Moreover, these days people prefer the adoption of smart technology in all the technological equipment that is being used, whether in research and development, medical diagnostic, or security scanning systems.
According to WHO stats, an approximated 3.6 billion diagnostic medical procedures, including X-rays, are carried out year globally. As more people receive medical care, this figure keeps rising. These procedures are carried out on kids under 15 in over 350 million cases.
Also, over the past ten years, the worldwide security screening sector has grown quickly due to the rise in threats and the necessity to prevent unethical and illegal behavior. The need for increased national and infrastructure security spending brought on by rapid economic expansion will continue to drive the adoption of dependable, cutting-edge technology-based security screening systems.
Emerging infectious diseases present a variety of radiological challenges, necessitating knowledge of both safe imaging procedures and disease transmission, as well as imaging characteristics that influence clinical therapy.
Rapid development in material science offers a great opportunity to revolutionize the future of X-ray imaging technology.
There is a tremendous chance to completely transform the direction of X-ray imaging techniques given the rapid advancement in material science. High-performance X-ray imaging has become increasingly dependent on scintillator materials, which can transform high-energy radiation into UV-Vis photons.
The creation of flexible X-ray detectors that may be used for 3D X-ray imaging of oddly shaped objects is another area of current research that has received attention. X-ray luminescence extension imaging with high resolution and flexibility has only recently been made possible by the development of lanthanide-doped fluoride materials made using wet chemical techniques.
The emergence of AI-aided X-ray systems and the interpretation of images will also lead to more opportunities for imaging procedures in the forecast years. The incorporation of artificial intelligence (AI) in diagnostic imaging, including but not limited to image processing and interpretation, is one of the most attractive areas of health innovation. AI is anticipated to have a significant impact on the daily lives of radiologists due to its numerous uses.
Owing to the aforementioned factors, the diagnostic x-ray system market is expected to grow at a CAGR of about 6.1% in the projected years.
There is enormous scope for growth in the diagnostic X-ray system market but some factors are still pertinent to restrict its growth.
There is quite a high cost of complex radiological imaging procedures and devices accompanied by large out-of-pocket expenses prevailing in the USA as more consumers acquire health insurance using high deductible plans. Patients and families that must make large co-payments for imaging studies frequently ask why they are being charged so much and frequently choose alternatives with lower fees.
Also, there are long-term side effects of radiation exposure. According to WHO stats, 20% of the population is exposed to radiation due to medical purposes, which accounts for 98% of the population's dosage exposure from all artificial sources. Ionizing radiation is a health concern, as it can destroy tissue and DNA in genes because it can damage the atoms in living organisms.
There is also the availability of safer alternative imaging procedures. Apart from conventional X-ray systems and devices, there have been developments in safer alternatives that give faster and more accurate results. These imaging procedures also provide less exposure to ionizing radiation and are less time-consuming in medical applications.
The above-mentioned factors can limit the growth of the diagnostic x-ray system market.
The USA dominated the North American region with a total market share of about 89.4% in 2021 and is expected to continue to experience the same growth throughout the forecast period.
According to the National Library of Medicine, infectious diseases are the main cause of disability, the second leading cause of mortality, and the third major reason of death in the USA, trailing behind heart disease and cancer. This accounts for increased medical diagnostic procedures in the USA and hence a larger market in diagnostic X-ray systems. Also, electronic equipment with more advancement is a part of its economy, which always keeps the USA diagnostic X-ray system market larger than the others.
Japan is set to exhibit good growth with a current market share of 37.4% of diagnostic X-ray systems in the East Asia market during the forecast period.
According to the Statistics Bureau of Japan, the proportion of people in Japan who were 65 or older in 2020 was 28.6 percent, higher than the USA (16.6 percent), Sweden (20.3%), France (20.8%), Germany (21.7 percent), as well as Italy (23.3 percent), showing that Japan's aging society is developing more quickly than that of the USA and other European nations. This will lead to more diagnostic procedures in Japan due to age-related factors such as osteoarthritis or fall fractures, of which X-ray is an important part. And also, since Japan is always ahead in technological advancement, the manufacturing companies for these systems and major players are also present there in large numbers, which will drive the market towards attractive growth in the future.
China dominates the East-Asian region with a total market share of over 40% in 2021 and is expected to continue to experience the same growth throughout the forecast period.
The Chinese market is full of major players in the manufacturing of medical devices and other imaging systems. And since there is a huge amount of export from the Chinese market, the market here is extremely lucrative and can project great opportunities in the future as well.
India has the largest share over 48.0%, in the South-Asia market in 2021.
The need for increased national and infrastructure security spending brought on by rapid economic expansion will continue to drive the adoption of dependable, cutting-edge technology-based security screening systems. There are now more hospitals and diagnostic labs because of the country's expanding healthcare infrastructure. The Indian government is committed to improving the manufacturing ecosystem and has chosen the medical device industry as a priority sector for its flagship Make in India program. The Indian medical device market is Asia's fourth-largest market for medical equipment. The Indian market currently depends heavily on imports, but exports have increased recently.
The Promotion of Medical Devices Parks Scheme and the Production Linked Incentive Scheme (PLI) has been cleverly designed to encourage large-scale manufacturing and to create the necessary infrastructure for the growth of manufacturing clusters in India.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Medical X-ray Devices have a current market value share of over 65% in the global market in 2021, but in contrast, the security systems are expected to show attractive growth with a CAGR of about 11.6% in the forecast years.
Post-COVID-19 pandemic, there was a huge upsurge in the medical diagnostic imaging sector, which led to an increase in the number of X-ray procedures. Infectious diseases are the main cause of disability, the second leading cause of mortality, and the third major reason of death in the USA, trailing behind heart disease and cancer.
The medical segment, using these X-ray systems, held the highest market share value of 54.7% during the year 2021.
The growing number of trauma cases, osteoporosis, and injuries has necessitated the demand for medical diagnosis using x-ray systems around the world.
As per a research article published in the Journal of Orthopaedic Surgery and Research, in 2021, the prevalence of osteoporosis is nearly 18.3% around the globe. Another published paper in Elsevier mentioned the incidence of long bone-related fractures to be around 406 out of every 1 lac person. musculoskeletal trauma poses a huge burden on the economy.
To guarantee that people in need receive treatment and counseling, access to diagnosis, medications, and basic health technology equipment in all primary healthcare facilities is crucial.
Hospitals held more than 60% of the global market revenue in 2021. But due to upcoming security norms and requirements, government facilities & homeland security, in the forecast years, are expected to show growth with a CAGR of about 8.5%.
The market for diagnostic X-Ray systems is highly fragmented. Increased application in the field of healthcare, as well as security purposes, has led many companies to enter the market by way of providing services or acquiring smaller companies offering these services in order to maintain as well as grow their current market position.
Similarly, recent developments related to companies manufacturing diagnostic x-ray systems have been tracked by the team at Future Market Insights, which are available in the full report.
Attributes | Details |
---|---|
Forecast Period | 2012 to 2021 |
Historical Data Available for | 2022 to 2032 |
Market Analysis | US$ Million for Value and Volume (Units) |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, South Africa |
Key Market Segments Covered | Product, Application, End User, and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
The global diagnostic x-ray system market is expected to be worth US$ 11.30 Billion in 2021 and is set to expand 1.8X over the next ten years.
The Diagnostic X-Ray System Market is expected to reach US$ 20.46 Billion by the end of 2032, with sales revenue expected to register a CAGR of about 6.1%.
The primary drivers of the market are the increasing burden of cardiovascular diseases, infectious diseases, growing advancement in X-ray systems technology, and increased initiatives by the government in medical device manufacturing.
USA, China, Japan, Germany, and India are expected to drive demand for the diagnostic X-Ray system market.
North America is one of the key markets for diagnostic X-ray system, with the USA accounting for about 89.4% of the North American diagnostic X-Ray system market in the year 2021.
China has the largest share of over 40% in the East Asia diagnostic x-ray system market.
Europe is one of the important markets for of diagnostic X-Ray system, with Germany accounting for about 22.8% of the European diagnostic x-ray system market in the year 2021.
The USA and China are the key producers of diagnostic X-Ray systems.
Oceania diagnostic X-Ray systems market is expected to grow at a projected CAGR of about 4.5%.
Shimadzu Corporation, Medlink Imaging, LLC, Konica Minolta Healthcare Americas, Inc., Leidos, ODSecurity, Rigaku Corporation, Anton Paar GmbH , Braun & Co. Limited, Xenoc, Proto Manufacturing, OSI Systems, Siemens Healthineers, General Electric Company, FUJIFILM Holdings Corp, Koninklijke Philips N.V., Carestream Health, Canon Medical Systems Corporation, Smiths Detection Group Ltd., Thermo Fisher Scientific Inc., Astrophysics Inc., Malvern Panalytical Ltd, NUCTECH COMPANY LTD and Bruker are s
1. Executive Summary | Diagnostic X-Ray System Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Key Strategies adopted by manufacturers
4.3. Recent Product Launches
4.4. Regulatory Scenario
4.5. Reimbursement Scenario
4.6. Technological Advancements
4.7. Porter’s Analysis
4.8. PESTLE Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Medical Imaging Equipment Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Increasing Adoption of Advanced Technologies
5.2.3. Increasing Installed Base of X-ray Systems
5.2.4. Life Span of the Device
5.2.5. Replacement Cycle
5.2.6. Cost of the product
5.2.7. New Technologies
5.2.8. Growing number of companies across all sectors
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. 2021 Market Scenario
6.2. COVID-19 and Impact Analysis
6.2.1. By Product
6.2.2. By Application
6.2.3. By End User
6.2.4. By Region
7. Global Market Volume Analysis 2014 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Volume (Units) Analysis, 2014 to 2021
7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Global Average Pricing Analysis Benchmark
8.2. Regional Average Pricing Analysis Benchmark
8.3. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
9.1. Historical Market Value (US$ Million) Analysis 2012 to 2021
9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Product, 2012 to 2021
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Product, 2022 to 2032
10.3.1. Medical X-ray Devices
10.3.1.1. Fixed/floor mounted
10.3.1.2. Mobile and Portable Devices
10.3.2. X-Ray Diffraction (XRD)
10.3.2.1. Powder Diffraction
10.3.2.2. High-Resolution XRD
10.3.2.3. Custom XRD
10.3.3. Security X-Ray Devices
10.3.3.1. Closed X-Ray Systems
10.3.3.2. Full body scanner
10.3.3.2.1. Single View
10.3.3.2.2. Dual View
10.3.4. X-Ray Fluorescence (XRF)
10.3.5. SAXS/WAXS
10.4. Market Attractiveness Analysis by Product
11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Application
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2022 to 2032
11.3.1. Medical
11.3.2. Research and Development
11.3.3. Security
11.4. Market Attractiveness Analysis by Application
12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis by End User, 2012 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2022 to 2032
12.3.1. Hospital
12.3.2. Diagnostic Imaging Centers
12.3.3. Airports
12.3.4. Malls
12.3.5. Railway & Metro Stations
12.3.6. Government Facilities & Homeland Security
12.4. Market Attractiveness Analysis by End User
13. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis by Region, 2012 to 2021
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Region, 2022 to 2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East & Africa
13.4. Market Attractiveness Analysis by Region
14. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
14.3.1. By Country
14.3.1.1. United States of America
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Product
14.4.2. By Application
14.4.3. By End User
14.4.4. By Country
14.5. Country-Level Analysis & Forecast
14.5.1. USA Market
14.5.1.1. Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Product
14.5.1.2.2. By Application
14.5.1.2.3. By End User
14.5.2. Canada Market
14.5.3. Introduction
14.5.4. Market Analysis and Forecast by Market Taxonomy
14.5.4.1.1. By Product
14.5.4.1.2. By Application
14.5.4.1.3. By End User
15. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2012 to 2021
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Rest of Latin America
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Application
15.4.3. By End User
15.4.4. By Country
15.5. Country-Level Analysis & Forecast
15.5.1. Brazil Market
15.5.1.1. Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Product
15.5.1.2.2. By Application
15.5.1.2.3. By End User
15.5.2. Mexico Market
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Product
15.5.2.2.2. By Application
15.5.2.2.3. By End User
16. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. France
16.3.1.3. Italy
16.3.1.4. Spain
16.3.1.5. United Kingdom
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Product
16.4.2. By Application
16.4.3. By End User
16.4.4. By Country
16.5. Country-Level Analysis & Forecast
16.5.1. Germany Market
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Application
16.5.1.2.3. By End User
16.5.2. France Market
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Application
16.5.2.2.3. By End User
16.5.3. Italy Market
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Product
16.5.3.2.2. By Application
16.5.3.2.3. By End User
16.5.4. Spain Market
16.5.4.1. Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Product
16.5.4.2.2. By Application
16.5.4.2.3. By End User
16.5.5. UK Market
16.5.5.1. Introduction
16.5.5.2. Market Analysis and Forecast by Market Taxonomy
16.5.5.2.1. By Product
16.5.5.2.2. By Application
16.5.5.2.3. By End User
16.5.6. BENELUX Market
16.5.6.1. Introduction
16.5.6.2. Market Analysis and Forecast by Market Taxonomy
16.5.6.2.1. By Product
16.5.6.2.2. By Application
16.5.6.2.3. By End User
16.5.7. Russia Market
16.5.7.1. Introduction
16.5.7.2. Market Analysis and Forecast by Market Taxonomy
16.5.7.2.1. By Product
16.5.7.2.2. By Application
16.5.7.2.3. By End User
17. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Product
17.4.2. By Application
17.4.3. By End User
17.4.4. By Country
17.5. Country-Level Analysis & Forecast
17.5.1. India Market
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Application
17.5.1.2.3. By End User
17.5.2. Thailand Market
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Application
17.5.2.2.3. By End User
17.5.3. Indonesia Market
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Application
17.5.3.2.3. By End User
17.5.4. Malaysia Market
17.5.4.1. Introduction
17.5.4.2. Market Analysis and Forecast by Market Taxonomy
17.5.4.2.1. By Product
17.5.4.2.2. By Application
17.5.4.2.3. By End User
18. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.4.2. By Application
18.4.3. By End User
18.4.4. By Country
18.5. Country-Level Analysis & Forecast
18.5.1. China Market
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Application
18.5.1.2.3. By End User
18.5.2. Japan Market
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Application
18.5.2.2.3. By End User
18.5.3. South Korea Market
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product
18.5.3.2.2. By Application
18.5.3.2.3. By End User
19. Oceania Market Analysis 2012 to 2021 and Forecast 2022 to 2032
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Product
19.4.2. By Application
19.4.3. By End User
19.4.4. By Country
19.5. Country-Level Analysis & Forecast
19.5.1. Australia Market
19.5.1.1. Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Application
19.5.1.2.3. By End User
19.5.2. New Zealand Market
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Application
19.5.2.2.3. By End User
20. Middle East and Africa Market Analysis 2012 to 2021 and Forecast 2022 to 2032
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2022 to 2032
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Application
20.3.4. By End User
20.3.5. By Country
20.4. Market Attractiveness Analysis
20.4.1. By Product
20.4.2. By Application
20.4.3. By End User
20.5. Country-Level Analysis & Forecast
20.5.1. GCC Countries Market
20.5.1.1. Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Product
20.5.1.2.2. By Application
20.5.1.2.3. By End User
20.5.2. Turkey Market
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Product
20.5.2.2.2. By Application
20.5.2.2.3. By End User
20.5.2.2.4. By End User
20.5.3. South Africa Market
20.5.3.1. Introduction
20.5.3.2. Market Analysis and Forecast by Market Taxonomy
20.5.3.2.1. By Product
20.5.3.2.2. By Application
20.5.3.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Deep Dive
22.2.1. Shimadzu Corporation
22.2.1.1. Overview
22.2.1.2. Product Overview
22.2.1.3. Key Financials
22.2.1.4. SWOT Analysis
22.2.1.5. Key Developments
22.2.1.6. Strategy Overview
22.2.2. Medlink Imaging, LLC
22.2.2.1. Overview
22.2.2.2. Product Overview
22.2.2.3. Key Financials
22.2.2.4. SWOT Analysis
22.2.2.5. Key Developments
22.2.2.6. Strategy Overview
22.2.3. Konica Minolta Healthcare Americas, Inc.
22.2.3.1. Overview
22.2.3.2. Product Overview
22.2.3.3. Key Financials
22.2.3.4. SWOT Analysis
22.2.3.5. Key Developments
22.2.3.6. Strategy Overview
22.2.4. Leidos
22.2.4.1. Overview
22.2.4.2. Product Overview
22.2.4.3. Key Financials
22.2.4.4. SWOT Analysis
22.2.4.5. Key Developments
22.2.4.6. Strategy Overview
22.2.5. ODSecurity
22.2.5.1. Overview
22.2.5.2. Product Overview
22.2.5.3. Key Financials
22.2.5.4. SWOT Analysis
22.2.5.5. Key Developments
22.2.5.6. Strategy Overview
22.2.6. Rigaku Corporation
22.2.6.1. Overview
22.2.6.2. Product Overview
22.2.6.3. Key Financials
22.2.6.4. SWOT Analysis
22.2.6.5. Key Developments
22.2.6.6. Strategy Overview
22.2.7. Anton Paar GmbH
22.2.7.1. Overview
22.2.7.2. Product Overview
22.2.7.3. Key Financials
22.2.7.4. SWOT Analysis
22.2.7.5. Key Developments
22.2.7.6. Strategy Overview
22.2.8. Braun & Co. Limited
22.2.8.1. Overview
22.2.8.2. Product Overview
22.2.8.3. Key Financials
22.2.8.4. SWOT Analysis
22.2.8.5. Key Developments
22.2.8.6. Strategy Overview
22.2.9. Xenoc
22.2.9.1. Overview
22.2.9.2. Product Overview
22.2.9.3. Key Financials
22.2.9.4. SWOT Analysis
22.2.9.5. Key Developments
22.2.9.6. Strategy Overview
22.2.10. Proto Manufacturing
22.2.10.1. Overview
22.2.10.2. Product Overview
22.2.10.3. Key Financials
22.2.10.4. SWOT Analysis
22.2.10.5. Key Developments
22.2.10.6. Strategy Overview
22.2.11. OSI Systems
22.2.11.1. Overview
22.2.11.2. Product Overview
22.2.11.3. Key Financials
22.2.11.4. SWOT Analysis
22.2.11.5. Key Developments
22.2.11.6. Strategy Overview
22.2.12. Siemens Healthineers
22.2.12.1. Overview
22.2.12.2. Product Overview
22.2.12.3. Key Financials
22.2.12.4. SWOT Analysis
22.2.12.5. Key Developments
22.2.12.6. Strategy Overview
22.2.13. General Electric Company
22.2.13.1. Overview
22.2.13.2. Product Overview
22.2.13.3. Key Financials
22.2.13.4. SWOT Analysis
22.2.13.5. Key Developments
22.2.13.6. Strategy Overview
22.2.14. FUJIFILM Holdings Corp
22.2.14.1. Overview
22.2.14.2. Product Overview
22.2.14.3. Key Financials
22.2.14.4. SWOT Analysis
22.2.14.5. Key Developments
22.2.14.6. Strategy Overview
22.2.15. Koninklijke Philips N.V.
22.2.15.1. Overview
22.2.15.2. Product Overview
22.2.15.3. Key Financials
22.2.15.4. SWOT Analysis
22.2.15.5. Key Developments
22.2.15.6. Strategy Overview
22.2.16. Carestream Health
22.2.16.1. Overview
22.2.16.2. Product Overview
22.2.16.3. Key Financials
22.2.16.4. SWOT Analysis
22.2.16.5. Key Developments
22.2.16.6. Strategy Overview
22.2.17. Canon Medical Systems Corporation
22.2.17.1. Overview
22.2.17.2. Product Overview
22.2.17.3. Key Financials
22.2.17.4. SWOT Analysis
22.2.17.5. Key Developments
22.2.17.6. Strategy Overview
22.2.18. Smiths Detection Group Ltd
22.2.18.1. Overview
22.2.18.2. Product Overview
22.2.18.3. Key Financials
22.2.18.4. SWOT Analysis
22.2.18.5. Key Developments
22.2.18.6. Strategy Overview
22.2.19. Thermo Fisher Scientific Inc
22.2.19.1. Overview
22.2.19.2. Product Overview
22.2.19.3. Key Financials
22.2.19.4. SWOT Analysis
22.2.19.5. Key Developments
22.2.19.6. Strategy Overview.
22.2.20. Astrophysics Inc.
22.2.20.1. Overview
22.2.20.2. Product Overview
22.2.20.3. Key Financials
22.2.20.4. SWOT Analysis
22.2.20.5. Key Developments
22.2.20.6. Strategy Overview
22.2.21. Malvern Panalytical Ltd
22.2.21.1. Overview
22.2.21.2. Product Overview
22.2.21.3. Key Financials
22.2.21.4. SWOT Analysis
22.2.21.5. Key Developments
22.2.21.6. Strategy Overview
22.2.22. NUCTECH COMPANY LTD
22.2.22.1. Overview
22.2.22.2. Product Overview
22.2.22.3. Key Financials
22.2.22.4. SWOT Analysis
22.2.22.5. Key Developments
22.2.22.6. Strategy Overview
22.2.23. Bruker.
22.2.23.1. Overview
22.2.23.2. Product Overview
22.2.23.3. Key Financials
22.2.23.4. SWOT Analysis
22.2.23.5. Key Developments
22.2.23.6. Strategy Overview
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports